Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells
- 14 December 2015
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 75 (24) , 5355-5366
Abstract
The treatment of glioblastoma (GBM) remains challenging in part due to the presence of stem-like tumor-propagating cells that are resistant to standard therapies consisting of radiation and temozolomide. Among the novel and targeted agents under evaluation for the treatment of GBM are BRAF/MAPK inhibitors, but their effects on tumor-propagating cells are unclear. Here, we characterized the behaviors of CD133+ tumor-propagating cells isolated from primary GBM cell lines. We show that CD133+ cells exhibited decreased sensitivity to the antiproliferative effects of BRAF/MAPK inhibition compared to CD133− cells. Furthermore, CD133+ cells exhibited an extended G2–M phase and increased polarized asymmetric cell divisions. At the molecular level, we observed that polo-like kinase (PLK) 1 activity was elevated in CD133+ cells, prompting our investigation of BRAF/PLK1 combination treatment effects in an orthotopic GBM xenograft model. Combined inhibition of BRAF and PLK1 resulted in significantly greater antiproliferative and proapoptotic effects beyond those achieved by monotherapy (P < 0.05). We propose that PLK1 activity controls a polarity checkpoint and compensates for BRAF/MAPK inhibition in CD133+ cells, suggesting the need for concurrent PLK1 inhibition to improve antitumor activity against a therapy-resistant cell compartment. Cancer Res; 75(24); 5355–66. ©2015 AACR.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Non-Stem Cell Origin for OligodendrogliomaCancer Cell, 2010
- SPAT-1/Bora acts with Polo-like kinase 1 to regulate PAR polarity and cell cycle progressionDevelopment, 2010
- Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiationJournal of Neurosurgery, 2010
- Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of OriginCancer Research, 2010
- Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant AstrocytomasCancer Research, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic AlterationsPLOS ONE, 2009
- Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolutionOncogene, 2009
- PAR proteins direct asymmetry of the cell cycle regulators Polo-like kinase and Cdc25Journal of Cell Biology, 2008
- Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating PonNature, 2007